Why US Healthcare Is Broken — and Why AI Alone Won’t Save It with Dr. David Levy

In a recent episode of Digital Health Interviews, we sat down with Dr. David Levy - physician, entrepreneur, former Global Healthcare Leader at PwC, founder of Franklin Health, and one of the early pioneers of complex care management in the United States.

Few people have witnessed the evolution of the American healthcare system from as many angles as Levy. He has practiced primary care, built one of the country's first outsourced complex care management companies, advised governments after Hurricane Katrina, led global healthcare initiatives at PwC, turned around healthcare companies, and now mentors the next generation of entrepreneurs. After more than forty years in healthcare, however, his conclusion is surprisingly blunt: the U.S. healthcare system is worse today than when he entered medicine. The reason, he argues, is not technology. It is mathematics.

Healthcare's Biggest Problems Were Solved Decades Ago, Then Forgotten

Levy never set out to leave medicine. Instead, he viewed entrepreneurship as an extension of public health. While running a primary care practice in New Jersey during the late 1980s, he began working with Western Union, which was struggling under enormous healthcare costs driven by retirees with multiple chronic conditions. The more deeply he became involved, the more he realized something fundamental: the sickest patients weren't simply expensive; they were receiving fragmented, reactive, and often inappropriate care. About 1% of patients accounted for roughly 1/3 of healthcare spending, yet the system repeatedly cycled them through hospital admissions without improving either quality of life or outcomes.

That observation led to the founding of Franklin Health, one of the first companies in the U.S. focused on what Levy coined "complex care management." Rather than managing catastrophic events after they occurred, his team placed advocates directly in patients' homes, coordinated care among physicians, emphasized palliative care when appropriate, and dramatically reduced unnecessary hospitalizations. Today these ideas sound familiar. Three decades ago, they were revolutionary.

Home-Based Care Isn't the Future. It Was the Past.

One of the strongest themes throughout the conversation is Levy's frustration that healthcare continues to rediscover ideas it already proved decades earlier. Franklin Health was among the first organizations promoting home-based palliative care, pain management at home, and alternatives to repeated hospital admissions. Academic studies validated these approaches in the early 2000s, yet many conferences today present them as entirely innovations. For Levy, this isn't simply disappointing; it reflects a healthcare system that struggles to learn from its own history.

Patients overwhelmingly prefer receiving care at home whenever possible. Hospitals remain essential for acute treatment, but they should not be the default environment for managing every stage of illness, particularly the final stages of life. The evidence has existed for years. The system simply failed to institutionalize it.

The Real Problem Isn't Capitalism

When discussions about U.S. healthcare become political, they often focus on capitalism versus public healthcare. Levy believes that debate misses the point entirely. According to him, nearly every developed country operates within capitalist economies while maintaining dramatically more efficient healthcare systems. The distinguishing factor is not ideology; it is structure. Specifically, he identifies one fundamental design flaw: employer-based health insurance.

Unlike countries that maintain a single foundational risk pool with optional private coverage layered on top, the United States fragments healthcare into thousands of separate employer groups, contracts, and insurance arrangements. That fragmentation creates cascading consequences. Administrative complexity explodes, negotiating power disappears, pricing becomes inconsistent, risk pools become unstable, and incentives increasingly reward manipulating financial structures instead of improving patient outcomes. In Levy's view, these are not isolated inefficiencies; they are mathematical consequences of how the system is organized.

Why Healthcare Keeps Getting More Expensive

Levy estimates that the United States now spends roughly $5 trillion annually on healthcare, with approximately $2 trillion representing waste. The problem is not simply high prices. It is that every participant is operating exactly as the system encourages them to operate. Providers negotiate separate contracts, health plans optimize risk adjustment, private equity identifies excess spending as an investment opportunity, employers compete using health benefits, and insurers build increasingly complex administrative processes. None of these behaviors are irrational. The incentives themselves are.

Rather than producing coordinated care, fragmented incentives generate fragmented outcomes. Levy argues that many current reform efforts, including value-based care initiatives, attempt to optimize around the edges of this fragmented structure without addressing its underlying mathematical instability. Until the structure changes, costs will continue rising regardless of technological progress.

Job Lock: The Hidden Economic Cost

One of Levy's lesser-discussed observations concerns entrepreneurship itself. Employer-sponsored insurance doesn't merely shape healthcare. It shapes labor markets. Millions of employees remain in jobs they no longer want because leaving would also mean losing healthcare coverage for themselves or their families. This "benefit lock" reduces workforce mobility, suppresses entrepreneurship, and limits innovation across the broader economy.

Healthcare, in this sense, becomes more than a medical issue. It becomes an economic constraint. Levy believes a unified national risk pool would not only stabilize healthcare financing but also unlock entrepreneurial activity by removing healthcare as a barrier to career mobility.

AI Can Either Heal the System, or Weaponize It

Naturally, the conversation turns to artificial intelligence. Unlike many commentators, Levy does not question AI's transformative potential. He questions how existing institutions will choose to use it. Today, much of AI deployment within healthcare focuses on administrative optimization, reducing utilization, denying claims more efficiently, lowering operational costs, and strengthening payer leverage. From a business perspective, these applications make sense. From a healthcare perspective, they risk reinforcing the very structural problems already undermining patient care.

Levy calls this the "weaponization" of AI. But he also sees another possibility. Instead of optimizing bureaucracy, AI could rebuild the fragmented patient experience. It could strengthen primary care, personalize prevention, integrate medical and social information, and shift healthcare toward a genuinely patient-centered model. The technology itself is neutral. Whether AI improves healthcare or deepens its existing problems depends almost entirely on the incentives surrounding its deployment.

Disease Is Not the Same as Illness

One of the interview's most memorable distinctions comes from Levy's discussion of disease versus illness. Disease, he explains, is biological. Illness is social, emotional, and personal. Modern healthcare excels at treating disease. It often struggles to understand illness.

This difference matters because patients rarely experience diagnoses in isolation. They experience fear, family dynamics, financial stress, cultural expectations, functional limitations, and uncertainty. These are dimensions that traditional provider-centered healthcare often overlooks. Levy believes AI could help bridge that gap, not by replacing physicians, but by supporting more holistic, personalized care that accounts for how patients actually live rather than simply what diagnoses they carry.

Prevention Before Longevity

The conversation eventually shifts toward longevity, a field currently attracting enormous investment and media attention. Levy remains unconvinced that extending maximum human lifespan should be healthcare's primary objective. Instead, he argues for improving health across the existing lifespan. Most increases in average life expectancy over the past century resulted from reductions in infant mortality, infectious disease, smoking, and better public health, not from extending the biological limits of human aging.

Rather than focusing on helping a small number of people live to 120 or beyond, he believes society should prioritize ensuring that as many people as possible reach healthy old age through prevention, exercise, nutrition, access to care, and public health infrastructure. In his words, the greatest opportunity lies in improving life from zero to one hundred, not chasing speculative breakthroughs beyond that.

Why Founders Think About Exit Too Early

Toward the end of the conversation, Levy offers advice that reflects decades of building healthcare businesses. His criticism is not aimed at technology; it is aimed at the founder mindset. Too many entrepreneurs, he argues, think about fundraising and exits before they fully understand the problem they are solving.

The first investor should not be venture capital. It should be a customer. Real customers validate value, refine business models, generate revenue without dilution, and perhaps most importantly, force founders to stay grounded in real-world problems rather than investor narratives. Levy himself built Franklin Health largely through customer revenue and strategic partnerships before external capital ever became central to the business. For healthcare startups especially, that lesson remains remarkably relevant.

Healthcare Doesn't Need Better Technology Alone

Perhaps the biggest takeaway from the conversation is that technology is rarely the primary constraint. Healthcare has no shortage of innovation. It has a shortage of alignment. Better AI will not fix fragmented incentives. Better algorithms will not solve structural financing problems. More sophisticated digital tools cannot compensate for a system optimized around conflicting objectives.

But if technology is combined with structural reform, and built around patients instead of institutions, it could become one of the most significant catalysts healthcare has seen in decades. As Levy sees it, the next few years may determine which path the industry chooses.